Marina-Kleopatra Boziki
Overview
Explore the profile of Marina-Kleopatra Boziki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
22
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stavropoulou De Lorenzo S, Andravizou A, Alexopoulos H, Michailidou I, Bokas A, Kesidou E, et al.
Biomedicines
. 2024 Jun;
12(6).
PMID: 38927526
The use of immune checkpoint inhibitors (ICIs) for the treatment of various advanced and aggressive types of malignancy has significantly increased both survival and long-term remission rates. ICIs block crucial...
2.
Karafoulidou E, Kesidou E, Theotokis P, Konstantinou C, Nella M, Michailidou I, et al.
Cells
. 2024 May;
13(9.
PMID: 38727321
Spinal muscular atrophy (SMA) is a neurodegenerative disease caused by deficiency of the survival motor neuron (SMN) protein. Although SMA is a genetic disease, environmental factors contribute to disease progression....
3.
Andravizou A, Stavropoulou De Lorenzo S, Kesidou E, Michailidou I, Parissis D, Boziki M, et al.
Healthcare (Basel)
. 2024 Apr;
12(7).
PMID: 38610190
Choroid plexus (CP) can be seen as a watchtower of the central nervous system (CNS) that actively regulates CNS homeostasis. A growing body of literature suggests that CP alterations are...
4.
Grigoriadis P, Bakirtzis C, Nteli E, Boziki M, Kotoumpa M, Theotokis P, et al.
Brain Sci
. 2024 Mar;
14(3).
PMID: 38539625
While cognitive abilities in people with multiple sclerosis (PwMS) have been studied in detail, little is known about linguistic abilities in PwMS and their relation to cognitive impairment. In this...
5.
Kountouras J, Boziki M, Tzitiridou-Chatzopoulou M, Zavos C, Kazakos E
Neurol Sci
. 2024 Feb;
45(7):3543-3544.
PMID: 38409472
No abstract available.
6.
Nikolaidis I, Karakasi M, Pilalas D, Boziki M, Tsachouridou O, Kourelis A, et al.
J Neurovirol
. 2023 Sep;
29(5):626-639.
PMID: 37695541
Relatively little research has been done in recent years to understand what leads to the unceasingly high rates of HIV sensory neuropathy despite successful antiretroviral treatment. In vivo and in...
7.
Bakirtzis C, Konstantinidou N, Stavropoulou De Lorenzo S, Moysiadis T, Boziki M, Grigoriadou E, et al.
J Clin Med
. 2023 Sep;
12(17).
PMID: 37685528
Over the past three years, humanity faced the abrupt spread of COVID-19, responsible for a worldwide health crisis. Initially, it was believed that individuals with chronic disorders, including multiple sclerosis,...
8.
Bakirtzis C, Boziki M, Grigoriadis N
Healthcare (Basel)
. 2023 Aug;
11(16).
PMID: 37628546
Chronic neurodegenerative diseases encompass a wide spectrum of disorders and affect millions of people worldwide [...].
9.
Bakirtzis C, Lima M, Stavropoulou De Lorenzo S, Artemiadis A, Theotokis P, Kesidou E, et al.
Healthcare (Basel)
. 2023 Aug;
11(15).
PMID: 37570367
Secondary demyelinating diseases comprise a wide spectrum group of pathological conditions and may either be attributed to a disorder primarily affecting the neurons or axons, followed by demyelination, or to...
10.
Bakirtzis C, Nikolaidis I, Boziki M, Grigoriadou E, Karakasi M, Moysiadis T, et al.
Int J MS Care
. 2023 Jul;
25(4):140-144.
PMID: 37469336
Background: Besides disease-modifying therapies, various pharmacologic agents are frequently prescribed to people with multiple sclerosis (MS) for symptom treatment and for comorbid conditions. The present study aims to investigate the...